alkyl lysophospholipids ( alp ) are synthetic analogues of lysophosphatidylcholine and represent a new generation of antitumor drugs currently being tested in phase-i trials in patients with cancer .
C0024367
lysophospholipids
C0024360
lysophosphatidylcholine